Cargando…

Clinical Results of Mentor MemoryGel Xtra Breast Implants From the GLOW Clinical Trial

BACKGROUND: Mentor MemoryGel Xtra breast implants (Mentor Worldwide LLC, Irvine, CA) were designed to maintain the soft, natural feel of MemoryGel implants while increasing fullness and projection and minimizing wrinkling, rippling, and related complications through optimization of shell gel-fill. O...

Descripción completa

Detalles Bibliográficos
Autores principales: Alderman, Amy, Caplin, David, Hammond, Dennis C, Keane, Alexandra, Turetzky, Jay, Kane, William J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10653354/
https://www.ncbi.nlm.nih.gov/pubmed/37610252
http://dx.doi.org/10.1093/asj/sjad272
_version_ 1785136393373089792
author Alderman, Amy
Caplin, David
Hammond, Dennis C
Keane, Alexandra
Turetzky, Jay
Kane, William J
author_facet Alderman, Amy
Caplin, David
Hammond, Dennis C
Keane, Alexandra
Turetzky, Jay
Kane, William J
author_sort Alderman, Amy
collection PubMed
description BACKGROUND: Mentor MemoryGel Xtra breast implants (Mentor Worldwide LLC, Irvine, CA) were designed to maintain the soft, natural feel of MemoryGel implants while increasing fullness and projection and minimizing wrinkling, rippling, and related complications through optimization of shell gel-fill. OBJECTIVES: To measure 3-year safety and effectiveness of MemoryGel Xtra breast implants in the Mentor MemoryGel and MemoryShape Combined Cohort Clinical Study. METHODS: Participants were implanted with MemoryGel Xtra breast implants in a prospective, multicenter clinical trial. Rates of complications and reoperations were analyzed to assess device safety and BREAST-Q was employed to assess device effectiveness. RESULTS: Two hundred eighty-seven females receiving MemoryGel Xtra breast implants were enrolled. Complication rates in the primary augmentation cohort included rates of 1.5% for implant-related reoperation, 2.3% for explantation, and 1.5% for Baker grade III or IV capsular contracture. For the revisional augmentation cohort, these rates were 2.8% for implant-related reoperation, 4.3% for explantation, and 3.0% for capsular contracture. For the primary reconstruction cohort, these rates were 12.0% for implant-related reoperation, 12.3% for explantation, and 7.3% for capsular contracture. For the revisional reconstruction cohort, these rates were 7.1% for capsular contracture, with zero implant-related reoperations or explantations. There were no reports of infection or implant malposition or displacement in any of these cohorts. Each cohort showed significantly improved satisfaction with breasts and psychosocial and sexual well-being at 1 year following the primary procedure. CONCLUSIONS: These data are consistent with legacy clinical data for MemoryGel and provide the first published safety and effectiveness data regarding the use of MemoryGel Xtra breast implants for breast augmentation and reconstruction. LEVEL OF EVIDENCE: 4: [Image: see text]
format Online
Article
Text
id pubmed-10653354
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-106533542023-08-23 Clinical Results of Mentor MemoryGel Xtra Breast Implants From the GLOW Clinical Trial Alderman, Amy Caplin, David Hammond, Dennis C Keane, Alexandra Turetzky, Jay Kane, William J Aesthet Surg J Original Article BACKGROUND: Mentor MemoryGel Xtra breast implants (Mentor Worldwide LLC, Irvine, CA) were designed to maintain the soft, natural feel of MemoryGel implants while increasing fullness and projection and minimizing wrinkling, rippling, and related complications through optimization of shell gel-fill. OBJECTIVES: To measure 3-year safety and effectiveness of MemoryGel Xtra breast implants in the Mentor MemoryGel and MemoryShape Combined Cohort Clinical Study. METHODS: Participants were implanted with MemoryGel Xtra breast implants in a prospective, multicenter clinical trial. Rates of complications and reoperations were analyzed to assess device safety and BREAST-Q was employed to assess device effectiveness. RESULTS: Two hundred eighty-seven females receiving MemoryGel Xtra breast implants were enrolled. Complication rates in the primary augmentation cohort included rates of 1.5% for implant-related reoperation, 2.3% for explantation, and 1.5% for Baker grade III or IV capsular contracture. For the revisional augmentation cohort, these rates were 2.8% for implant-related reoperation, 4.3% for explantation, and 3.0% for capsular contracture. For the primary reconstruction cohort, these rates were 12.0% for implant-related reoperation, 12.3% for explantation, and 7.3% for capsular contracture. For the revisional reconstruction cohort, these rates were 7.1% for capsular contracture, with zero implant-related reoperations or explantations. There were no reports of infection or implant malposition or displacement in any of these cohorts. Each cohort showed significantly improved satisfaction with breasts and psychosocial and sexual well-being at 1 year following the primary procedure. CONCLUSIONS: These data are consistent with legacy clinical data for MemoryGel and provide the first published safety and effectiveness data regarding the use of MemoryGel Xtra breast implants for breast augmentation and reconstruction. LEVEL OF EVIDENCE: 4: [Image: see text] Oxford University Press 2023-08-23 /pmc/articles/PMC10653354/ /pubmed/37610252 http://dx.doi.org/10.1093/asj/sjad272 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of The Aesthetic Society. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Alderman, Amy
Caplin, David
Hammond, Dennis C
Keane, Alexandra
Turetzky, Jay
Kane, William J
Clinical Results of Mentor MemoryGel Xtra Breast Implants From the GLOW Clinical Trial
title Clinical Results of Mentor MemoryGel Xtra Breast Implants From the GLOW Clinical Trial
title_full Clinical Results of Mentor MemoryGel Xtra Breast Implants From the GLOW Clinical Trial
title_fullStr Clinical Results of Mentor MemoryGel Xtra Breast Implants From the GLOW Clinical Trial
title_full_unstemmed Clinical Results of Mentor MemoryGel Xtra Breast Implants From the GLOW Clinical Trial
title_short Clinical Results of Mentor MemoryGel Xtra Breast Implants From the GLOW Clinical Trial
title_sort clinical results of mentor memorygel xtra breast implants from the glow clinical trial
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10653354/
https://www.ncbi.nlm.nih.gov/pubmed/37610252
http://dx.doi.org/10.1093/asj/sjad272
work_keys_str_mv AT aldermanamy clinicalresultsofmentormemorygelxtrabreastimplantsfromtheglowclinicaltrial
AT caplindavid clinicalresultsofmentormemorygelxtrabreastimplantsfromtheglowclinicaltrial
AT hammonddennisc clinicalresultsofmentormemorygelxtrabreastimplantsfromtheglowclinicaltrial
AT keanealexandra clinicalresultsofmentormemorygelxtrabreastimplantsfromtheglowclinicaltrial
AT turetzkyjay clinicalresultsofmentormemorygelxtrabreastimplantsfromtheglowclinicaltrial
AT kanewilliamj clinicalresultsofmentormemorygelxtrabreastimplantsfromtheglowclinicaltrial